Kläre Bryant, advanced clinical pharmacist in dermatology at Liverpool University Hospitals, was a recently-qualified independent prescriber when she managed the switch to biosimilar infliximab for the cohort of… read more.
Feedback from a satisfied patient illustrates the impact that good pharmaceutical care can have on dermatological disease, according to Kläre Bryant, advanced clinical pharmacist in dermatology at Liverpool… read more.
Kläre Bryant is an advanced clinical pharmacist who has been holding clinics for dermatology patients receiving biologics and other systemic treatments for more than nine years. IMI spoke… read more.
Professor M Lynn Crismon is the Behrens Centennial Professor of Pharmacy and Professor of Psychiatry at Dell Medical School at the University of Texas at Austin. In this… read more.
The coronavirus pandemic has had a huge impact on mental health in general but especially on health care workers and on children, according to Professor Lynn Crismon. Commenting… read more.
A request from the medical director to review the prescribing of psychotropic drugs in a small hospital serving the Navajo population stimulated a career interest in psychiatric disease… read more.
Early in his career Professor Lynn Crismon worked in the US Public Health Service on the Navajo reservation where he learned much about communicable diseases, including bubonic plague…. read more.
Professor M Lynn Crismon received the 2021 American Society of Health System Pharmacists award for excellence in pharmacy practice leadership. IMI spoke to him to find out more… read more.
For primary care teams, keeping up-to-date with developments and current best practice is the key to expediting ovarian cancer diagnosis, according to Dr Sharon Tate, Head of Primary… read more.
It is a complete myth that ovarian cancer is a silent killer – even early-stage disease causes symptoms and knowing what they are is key to early treatment,… read more.
Two thirds of UK women with ovarian cancer are diagnosed late when the cancer has spread and is difficult to treat. IMI spoke to Dr Sharon Tate, Head… read more.
Open discussion of the scientific evidence and the uncertainties could have generated less political polarisation, less wasted expenditure but built more trust, according to Allyson Pollock, Clinical Professor… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
